Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-02-10

Clinical Trial Update: Anal Fistula Repair With Platelet-rich Plasma [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating anal/rectal fistula repair with platelet-rich plasma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Rectal Fistula | Phase 4 | Status: WITHDRAWN